EUVIMED · CrossrefZeitschrift
International Journal of Neonatal Screening
ISSN 2409-515X · MDPI AG
Neueste Artikel
Nationwide Pilot Newborn Screening for Spinal Muscular Atrophy and Inborn Errors of Immunity in Greece
Two-Year Nationwide Newborn Screening for Severe Combined Immunodeficiency in Latvia—The First Experience in Baltic Countries
Restarting the Recommended Uniform Screening Panel (RUSP) Process: A New Way Forward for Newborn Screening in the United States
Performance Evaluation of Newborn Screening for Congenital Adrenal Hyperplasia: A Single Health System Clinical Audit in Pakistan
United States Public Health Laboratory Experiences with Krabbe Disease Newborn Screening After Recommendation at the National Level
A Decade of Neonatal Inherited Metabolic Disorder Screening Experience in Ningbo, China: Screening Performance, Disease Spectrum, and Genetic Characteristics
Haemoglobinopathies in Newborn Screening: Epidemiological Findings and Exploratory Analysis of HbA0 Distribution in a Population-Based Neonatal Cohort from Northern Italy
Five Years of Newborn Screening for Lysosomal Disorders in Indiana
Birth Prevalence of Sickle Cell Disease in India: A Systematic Review and Meta-Analysis
Cord Blood-Based Neonatal Screening for Hemoglobinopathies in Northern Tunisia
Newborn Screening for Metachromatic Leukodystrophy: A Systematic Literature Review
Refining CFTR-Related Metabolic Syndrome (CRMS)/Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) Diagnosis: Impact of CFTR2 Variant Classifications
Implementation of Neonatal Screening Program for Congenital Hypothyroidism in Eastern Morocco
Qatar’s National Expanded Metabolic Newborn Screening Program: Incidence and Outcomes
Newborn Screening for Gaucher Disease: The New Jersey Experience
Cystic Fibrosis Newborn Screening: A Systematic Review-Driven Consensus Guideline from the United States Cystic Fibrosis Foundation
Five-Year Outcomes of Patients with Pompe Disease Identified by the Pennsylvania Newborn Screen
Clinical Utility of the Addition of Molecular Genetic Testing to Newborn Screening for Hemoglobinopathies for Confirmation of Alpha-Thalassemia Trait
Sudden Death of a Four-Day-Old Newborn Due to Mitochondrial Trifunctional Protein/Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiencies and a Systematic Literature Review of Early Deaths of Neonates with Fatty Acid Oxidation Disorders
Advancing Newborn Screening in Washington State: A Novel Multiplexed LC-MS/MS Proteomic Assay for Wilson Disease and Inborn Errors of Immunity
Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide
Newborn Screening for Six Primary Conditions in a Clinical Setting in Morocco
Evaluation of a New Tandem Mass Spectrometry Method for Sickle Cell Disease Newborn Screening
Cystic Fibrosis Screening Efficacy and Seasonal Variation in California: 15-Year Comparison of IRT Cutoffs Versus Daily Percentile for First-Tier Testing
Incidence of Inborn Errors of Metabolism and Endocrine Disorders Among 40965 Newborn Infants at Riyadh Second Health Cluster of the Ministry of Health Saudi Arabia
Wilson and Jungner Revisited: Are Screening Criteria Fit for the 21st Century?
Consistency in the Assessment of Dried Blood Spot Specimen Size and Quality in U.K. Newborn Screening Laboratories
Our Journey from Individual Efforts to Nationwide Support: Implementing Newborn Screening for Spinal Muscular Atrophy in Serbia
Systematic Review of Presymptomatic Treatment for Spinal Muscular Atrophy
A Five-Year Review of Newborn Screening for Spinal Muscular Atrophy in the State of Utah: Lessons Learned
EUVIMED